Alzheimer's disease. Amyloid ox-tox transducers. (Q53212905)

12 May 2018

title

Alzheimer's disease. Amyloid ox-tox transducers. (English)

1 reference

12 May 2018

author name string

M P Mattson

series ordinal

1

1 reference

12 May 2018

R E Rydel

series ordinal

2

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 August 1996

1 reference

12 May 2018

published in

Nature

1 reference

12 May 2018

volume

382

1 reference

12 May 2018

issue

6593

1 reference

12 May 2018

page(s)

674-675

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/382674a0

exact match

0 references

cites work

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

7 January 2021

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death.

1 reference

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

7 January 2021

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

1 reference

7 January 2021

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

1 reference

7 January 2021

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

1 reference

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

7 January 2021

The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

1 reference

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

7 January 2021

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

7 January 2021

The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide

1 reference

7 January 2021

Identifiers

DOI

10.1038/382674A0

1 reference

12 May 2018

Dimensions Publication ID

0 references

1 reference

12 May 2018